spacer
home > pmps > autumn 2008 > cross-cultural comments
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Cross-Cultural Comments

The outsourcing of manufacturing and the subsequent transportation and distribution of pharmaceutical products involves the need to work increasingly with different countries – and therefore different cultures – around the world. This brings with it a set of cultural and communication challenges that need to be addressed if the business outcome is to be successful.

One of the challenges of working successfully with different cultures is that business must be conducted professionally within an environment that may have a different perception of what ‘professionalism’ is. In other words, as much as a Middle Eastern government may desire the kudos of manufacturing the region’s newest and most sophisticated medicines in its own back yard...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Paul Stiff, Intercultural Trainer at Farnham Castle International Briefing & Conference Centre, has spent over 25 years in the healthcare industry working in a variety of roles in Africa, the Middle East and Europe. Working initially in Sales at Novartis Group, and then in Marketing and Senior Management at GSK and more recently Astra Zeneca, he has had plenty of experience of the challenges facing companies manufacturing and selling in markets outside of Europe.
spacer
Paul Stiff
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Further Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility

Philadelphia, PA – June 4, 2019 PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has announced the growth of its West Coast Clinical operations with expansion into its third facility in San Diego.
More info >>

White Papers

Time lapse photography to demonstrate the potential antimicrobial abilities of Dycem contamination control flooring

Dycem

A defined volume of bioluminescent reporter bacteria was deposited onto 20 mm x 20 mm coupons of Dycem flooring, vinyl tile and ITW Alma tacky mat. Through monitoring of bacterial bioluminescence, metabolic inhibition was observed on all three surfaces however the effect occurred more rapidly on Dycem flooring than on vinyl or ITW Alma. Recovery counts after three hours of exposure to the floor surfaces showed between a 65% and 100% decrease in the number of viable organisms recovered from Dycem flooring compared to controls. On vinyl and ITW Alma flooring, there were slight increases in the number of viable survivors recovered compared to controls. Dycem flooring inhibited the metabolic activity and reduced the number of viable survivors recovered of Salmonella enterica Serovar Typhimurium DT104 pGLITE. It remains unclear as to whether this effect is attributable to the impregnated biocide or rapid drying of the inoculum on this surface.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement